Rochelle Naylor to Genetic Testing
This is a "connection" page, showing publications Rochelle Naylor has written about Genetic Testing.
Connection Strength
2.079
-
The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing. Diabetes Care. 2019 12; 42(12):2247-2255.
Score: 0.526
-
Pediatric Monogenic Diabetes: A Unique Challenge and Opportunity. Pediatr Ann. 2019 Aug 01; 48(8):e319-e325.
Score: 0.521
-
Cost-effectiveness of MODY genetic testing: translating genomic advances into practical health applications. Diabetes Care. 2014; 37(1):202-9.
Score: 0.346
-
Who should have genetic testing for maturity-onset diabetes of the young? Clin Endocrinol (Oxf). 2011 Oct; 75(4):422-6.
Score: 0.302
-
Economics of Genetic Testing for Diabetes. Curr Diab Rep. 2019 03 27; 19(5):23.
Score: 0.127
-
Monogenic Diabetes in Children and Adolescents: Recognition and Treatment Options. Curr Diab Rep. 2018 06 22; 18(8):58.
Score: 0.121
-
Sulfonylurea treatment before genetic testing in neonatal diabetes: pros and cons. J Clin Endocrinol Metab. 2014 Dec; 99(12):E2709-14.
Score: 0.094
-
Diagnosis, treatment and disclosure: A qualitative exploration of participant challenges in a Monogenic Diabetes Registry. Genet Med. 2023 04; 25(4):100019.
Score: 0.041